Deficiency of lncRNA MERRICAL abrogates macrophage chemotaxis and alleviates diabetes-associated atherosclerosis

1) Differential gene expression profiling of bone marrow derived macrophage treated with GapmeR NS (control) or MERRICAL (KD) in both M0 and M1 phase Overall design: M0 and M1 phase bone marrow derived macrophage was treated with GapmeR (NS) and (MERRICAL) for 16 hours, and RNA was collected to compare the transcriptome difference between KD and NS.